Gibbs Wealth Management »

Regeneron Pharmaceuticals shares owned by Gibbs Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Gibbs Wealth Management from 13F filings

Historical chart of Gibbs Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Gibbs Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Gibbs Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $299k 532 562.30
2025-06-30 $317k 604 525.01
2025-03-31 $266k 419 634.24

More positions owned by Gibbs Wealth Management

Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Spdr Series Trust Port Mtg Bk Etf (SPMB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Microsoft Corporation (MSFT)
Spdr Series Trust Portfolio Ln Tsr (SPTL)
NVIDIA Corporation (NVDA)
Oracle Corporation (ORCL)
Amazon (AMZN)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Spdr Series Trust Portfolio S&p600 (SPSM)

View all positions for Gibbs Wealth Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals